Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Politics : Formerly About Advanced Micro Devices -- Ignore unavailable to you. Want to Upgrade?

To: POKERSAM who wrote (1317737)	9/4/2021 1:24:20 PM
From: Wharf Rat	Read Replies (2) \| Respond to of 1571172

"It is time the American people stood up and said we have had enough. We want our freedom back and we will not tolerate the governments overreach into our private lives any longer." Is it OK for individuals to overreach into a stranger's uterus?

To: POKERSAM who wrote (1317737)	9/4/2021 3:53:29 PM
From: Winfastorlose	3 Recommendations Recommended By Mick Mørmøny POKERSAM tntpal Read Replies (1) \| Respond to of 1571172

Yes indeed. For example. According to the greedy sickos in our government and at Big Pharma, cheap Ivermectin bad. But the expensive clone of Ivermectin? EXCELLENT! The latest scam: Pfizer developing ivermectin clone that will cost 100x more… “Success against #COVID19 will likely require both vaccines & treatments,” Pfizer CEO Albert Bourla said on Wednesday. “We’re pleased to share we’ve started a Phase 2/3 study of our oral antiviral candidate-specifically designed to combat SARS-CoV-2-in non-hospitalized, low-risk adults.” Pfizer also put out a press release the same week that proclaimed, “If successful, [the drug] has the potential to address a significant unmet medical need, providing patients with a novel oral therapy that could be prescribed at the first sign of infection, without requiring hospitalization.”